References
- Avirutnan P., Malasit P., Seliger B., Bhakdi S., Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 1998; 161: 6338–6346, [PUBMED], [INFOTRIEVE]
- Banchereau J., Steinman R. M. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767–811, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bethell D. B., Flobbe K., Cao X. T., Day N. P., Pham T. P., Buurman W. A., Cardosa M. J., White N. J., Kwiatkowski D. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J. Infect. Dis. 1998; 177: 778–782, [PUBMED], [INFOTRIEVE]
- Bonini C., Lee S. P., Riddell S. R., Greenberg P. D. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. J. Immunol. 2001; 166: 5250–5257, [PUBMED], [INFOTRIEVE]
- Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000; 1: 305–310, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chaturvedi U. C., Elbishbishi E. A., Agarwal R., Raghupathy R., Nagar R., Tandon R., Pacsa A. S., Younis O. I., Azizieh F. Sequential production of cytokines by dengue virus‐infected human peripheral blood leukocyte cultures. J. Med. Virol. 1999; 59: 335–340, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Constant S. L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 1997; 15: 297–322, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- da Fonseca B. A., Fonseca S. N. Dengue virus infections. Curr. Opin. Pediatr. 2002; 14: 67–71, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W. I., Steinman R. M., Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999; 163: 6762–6768, [PUBMED], [INFOTRIEVE]
- Green S., Vaughn D. W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B. L., Kurane I., Rothman A. L., Ennis F. A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 1999a; 179: 755–762, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Green S., Vaughn D. W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Rothman A. L., Ennis F. A. Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity. J. Med. Virol. 1999b; 59: 329–334, [PUBMED], [INFOTRIEVE], [CSA]
- Grosjean I., Caux C., Bella C., Berger I., Wild F., Banchereau J., Kaiserlian D. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4 + T cells. J. Exp. Med. 1997; 186: 801–812, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gubler D. J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998; 11: 480–496, [PUBMED], [INFOTRIEVE], [CSA]
- Ho L. J., Wang J. J., Shaio M. F., Kao C. L., Chang D. M., Han S. W., Lai J. H. Infection of human dendritic cells by Dengue virus causes cell maturation and cytokine production. J. Immunol. 2001a; 166: 1499–1506, [PUBMED], [INFOTRIEVE]
- Ho L. J., Chang D. M., Shiau H. Y., Chen C. H., Hsieh T. Y., Hsu Y. L., Wong C. S., Lai J. H. Aspirin differentially regulates endotoxin‐induced IL‐12 and TNF‐α production in human dendritic cells. Scand. J. Rheumatol. 2001b; 30: 346–352, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hosken N. A., Shibuya K., Heath A. W., Murphy K. M., O'Garra A. The effect of antigen dose on CD4 + T helper cell phenotype development in a T cell receptor‐alpha beta‐transgenic model. J. Exp. Med. 1995; 182: 1579–1584, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Iezzi G., Scotet E., Scheidegger D., Lanzavecchia A. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 1999; 29: 4092–4101, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kanto T., Hayashi N., Takehara T., Tatsumi T., Kuzushita N., Ito A., Sasaki Y., Kasahara A., Hori M. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus‐infected individuals. J. Immunol. 1999; 162: 5584–5591, [PUBMED], [INFOTRIEVE]
- Knight S. C., Iqball S., Roberts M. S., Macatonia S., Bedford P. A. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 1998; 28: 1636–1644, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koraka P., Suharti C., Setiati T. E., Mairuhu A. T., Van Gorp E., Hack C. E., Juffrie M., Sutaryo J., Van Der Meer G. M., Groen J., Osterhaus A. D. Kinetics of dengue virus‐specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 2001; 39: 4332–4338, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kruse M., Rosorius O., Kratzer F., Stelz G., Kuhnt C., Schuler G., Hauber J., Steinkasserer A. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T‐cell stimulatory capacity. J. Virol. 2000; 74: 7127–7136, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kuchroo V. K., Das M. P., Brown J. A., Ranger A. M., Zamvil S. S., Sobel R. A., Weiner H. L., Nabavi N., Glimcher L. H. B7‐1 and B7‐2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707–718, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kurane I., Innis B. L., Nimmannitya S., Nisalak A., Meager A., Janus J., Ennis F. A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon‐gamma in sera of children with dengue. J. Clin. Invest. 1991; 88: 1473–1480, [PUBMED], [INFOTRIEVE], [CSA]
- Kurane I., Innis B. L., Hoke C. H., Jr., Eckels K. H., Meager A., Janus J., Ennis F. A. T cell activation in vivo by dengue virus infection. J. Clin. Lab. Immunol. 1995; 46: 35–40, [PUBMED], [INFOTRIEVE], [CSA]
- Lai J. H., Ho L. J., Kwan C. Y., Chang D. M., Lee T. C. Plant alkaloid tetrandrine and its analog block CD28‐costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation 1999; 68: 1383–1392, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lai J. H., Ho L. J., Lu K. C., Chang D. M., Shaio M. F., Han S. H. Western and Chinese antirheumatic drug‐induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 2001; 166: 6914–6924, [PUBMED], [INFOTRIEVE]
- Langenkamp A., Messi M., Lanzavecchia A., Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 2000; 1: 311–316, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lei H. Y., Yeh T. M., Liu H. S., Lin Y. S., Chen S. H., Liu C. C. Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 2001; 8: 377–388, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mathew A., Kurane I., Green S., Vaughn D. W., Kalayanarooj S., Suntayakorn S., Ennis F. A., Rothman A. L. Impaired T cell proliferation in acute dengue infection. J. Immunol. 1999; 162: 5609–5615, [PUBMED], [INFOTRIEVE]
- Oh S., Eichelberger M. C. Polarization of allogeneic T‐cell responses by influenza virus‐infected dendritic cells. J. Virol. 2000; 74: 7738–7744, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rothman A. L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 2003; 60: 397–419, [PUBMED], [INFOTRIEVE]
- Schnorr J. J., Xanthakos S., Keikavoussi P., Kampgen E., ter Meulen V., Schneider‐Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 5326–5331, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Steinbach F., Borchers K., Ricciardi‐Castagnoli P., Ludwig H., Stingl G., Elbe‐Burger A. Dendritic cells presenting equine herpesvirus‐1 antigens induce protective anti‐viral immunity. J. Gen. Virol. 1998; 79: 3005–3014, [PUBMED], [INFOTRIEVE], [CSA]
- Tassaneetrithep B., Burgess T. H., Granelli‐Piperno A., Trumpfheller C., Finke J., Sun W., Eller M. A., Pattanapanyasat K., Sarasombath S., Birx D. L., Steinman R. M., Schlesinger S., Marovich M. A. DC‐SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003; 197: 823–829, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S., Rothman A. L., Ennis F. A., Nisalak A. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 1997; 176: 322–330, [PUBMED], [INFOTRIEVE]
- Wu S.‐J. L., Grouard‐Vogel G., Sun W., Mascola J. R., Brachtel E., Putvatana R., Louder M. K., Filgueira L., Marovich M. A., Wong H. K., Blauvelt A., Murphy G. S., Robb M. L., Innes B. L., Birx D. L., Hayes C. G., Frankel S. S. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 2000; 6: 816–820, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]